TW393578B - A test device and method for the determination of protein in a biological sample - Google Patents

A test device and method for the determination of protein in a biological sample Download PDF

Info

Publication number
TW393578B
TW393578B TW84100273A TW84100273A TW393578B TW 393578 B TW393578 B TW 393578B TW 84100273 A TW84100273 A TW 84100273A TW 84100273 A TW84100273 A TW 84100273A TW 393578 B TW393578 B TW 393578B
Authority
TW
Taiwan
Prior art keywords
protein
polycarbonate
patent application
scope
application
Prior art date
Application number
TW84100273A
Other languages
Chinese (zh)
Inventor
James Albarella
Angela Michaels
Michael J Pugia
Ronald G Sommer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Priority to TW84100273A priority Critical patent/TW393578B/en
Application granted granted Critical
Publication of TW393578B publication Critical patent/TW393578B/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Description

其中: η定義爲重複聚醚數,爲介於4至15之一整數,較佳介於 4 至 1 1 ; m定義爲重複聚碳酸數,爲介於1至之一整數,較佳 介於1至7,最佳介於1至5。 起始物質聚乙鍵L 950是一種二官能基之聚丙二醇,平均 分子量約420’由環氧丙烷在12-丙二醇之存在下聚合製 得。每個二醇殘基生出一個聚合鏈,造成一種線性聚合物 ’其各端以二級獲基終結(即’有兩個官能性之經基)。得 自聚乙醚殘基與碳酸酯連接的聚乙醚-聚碳酸酯物質具下 列比例: HI- In n^il It^〆 ei mu mt^ —HI— \OJ /St (請先閲讀背面之注意事項再填寫本頁) 聚乙醚L 950 碳酸二苯基酯 Ti(OC4H9)4 amt(公克) 4248 1581 0.6 amt(莫爾) 10.22 7.39 0.0018 經濟部中央標準局員工消費合作杜印製 已發現限制脂族聚乙醚-聚碳酸酯物質之量至10 %重量計 或更低對於減少比重效應具重要性。有關降低濾紙效應, 已發現宜於降低脂族聚乙醚聚碳酸酯物質之量至百分之 二以重量計或更低。 展示下列實例揭述較佳具體實例及本發明之用途,並不 意味限制本發明,除非在後附的申請專利範圍中另有説明 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -τστ 經濟部中央標隼局員工消费合作社印聚Among them: η is defined as the number of repeated polyethers, which is an integer between 4 and 15, preferably between 4 and 1 1; m is defined as the number of repeated polycarbonates, which is an integer between 1 and 1, preferably between 1 and 7, preferably between 1 and 5. The starting material polyethylene bond L 950 is a difunctional polypropylene glycol having an average molecular weight of about 420 ', which is prepared by polymerizing propylene oxide in the presence of 12-propylene glycol. Each diol residue gives rise to a polymer chain, resulting in a linear polymer ′ whose ends are terminated with secondary radicals (that is, ′ has two functional radicals). The polyether-polycarbonate material obtained from the connection of polyether residues to carbonates has the following ratio: HI- In n ^ il It ^ 〆ei mu mt ^ —HI— \ OJ / St (Please read the precautions on the back first Refill this page) Polyether L 950 Diphenyl Carbonate Ti (OC4H9) 4 amt (g) 4248 1581 0.6 amt (Moore) 10.22 7.39 0.0018 The consumption cooperation of employees of the Central Standards Bureau of the Ministry of Economic Affairs has been found to restrict aliphatics. The amount of polyether-polycarbonate material to 10% by weight or less is important for reducing the specific gravity effect. Regarding the reduction of the filter paper effect, it has been found suitable to reduce the amount of the aliphatic polyether polycarbonate material to 2% by weight or less. The following examples are shown to disclose the preferred specific examples and the application of the present invention, which does not mean to limit the present invention, unless otherwise stated in the scope of the attached patent application. ) -Τστ Consumers' Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs

i明之範圍 2發明㈣蛋白質測定之方法,特別是,有關利用^ 一 ^指π劑,緩衝劍,及-種脂族聚碳酸醋(其责 "7或低於重量之百分之十)於生物試樣中測定蛋白質之 新穎組合物及方法。 兔景技藝之説明 生_物樣品中蛋白質存在的測定對於診斷數種影響腎臟, 循環系統及中樞神經的病理狀況極重要。因此,常需要定 量及/或定性測量尿中蛋白質(白蛋白)。此對於糖:病及 腎臟病之診斷尤其重要。棱尿病測量中的主要蛋白質是白 蛋白;因此蛋白尿試驗的模型系統是白蛋白。 已熟知測定尿中存在白蛋白之方法。測定白蛋白最便京 方便的方法係用 > 量尿液弄濕浸有蛋白質誤差指示劑的 測試條。若尿液樣品中存在白蛋白,試條會簡單的改變顏 色顯示。所出現的顏色一般依據樣品中白蛋白濃度而定。 使用此各種顏色變化定量樣品中的白蛋白。 雖然上述類型的測試條對染點測定蛋白質是方便且快速 的工具,但其中一個已發生的問題是所謂·的重力效應。一 般尿液蛋白質測試使用pH指示染料,此染料與蛋白質複合 時顯示pKa位移(pH指示劑之"蛋白質誤差,,)。此種方法對 於陰性反應之尿液與含有微量濃度蛋白質的尿液(約每公 合15微克)之間無法提供充份之區分,且在高比重的尿液 得到錯誤的陽性讀値。已發現添加某些聚碳酸酯化合物至 蛋白f誤差指示劑内會降低試劑紙的初反應性並減低對高The scope of the Ming 2 invention of the method for protein determination, in particular, the use of ^ ^ means π agent, buffer sword, and-a kind of aliphatic polycarbonate (its responsibility " 7 or less than ten percent by weight) Novel compositions and methods for measuring proteins in biological samples. The description of the rabbit scene technique The determination of the presence of proteins in biological samples is extremely important in diagnosing several pathological conditions affecting the kidneys, the circulatory system and the central nervous system. Therefore, quantitative and / or qualitative measurement of urine protein (albumin) is often required. This is especially important for the diagnosis of sugar: and kidney disease. The main protein in rheumatic urine measurement is albumin; therefore the model system for the proteinuria test is albumin. Methods for determining the presence of albumin in urine are well known. The most convenient method for measuring albumin is to wet the test strip impregnated with a protein error indicator with > urine. If albumin is present in the urine sample, the test strip will simply change its color display. The color that appears usually depends on the albumin concentration in the sample. Use this variety of color changes to quantify albumin in the sample. Although the above types of test strips are a convenient and fast tool for determining protein at the staining point, one of the problems that has occurred is the so-called gravity effect. The general urine protein test uses a pH indicator dye, which shows a pKa shift when it is complexed with a protein (the "protein error of the pH indicator,"). This method does not provide a sufficient distinction between negative urine and protein-containing urine (approximately 15 micrograms per kilogram), and gives false positive readings in urine with a high specific gravity. It has been found that the addition of certain polycarbonate compounds to the protein f error indicator reduces the initial reactivity of the reagent paper and reduces the

本紙張尺度適用中國國家標準(CNS > Λ4規格(210X29^J"J • 4 - A7 B7 經濟部t央標準局員工消费合作社印策 五、發明説明(2 既熏尿液樣品之傾向而得到蛋白質之陽性讀値。 此種裝置結構發生的另一個n 如問靖是吸收材料,通常是滹 紙,與系統中所用之試劑未且右.卜 " 、有恆定的(即,均一的)反庳 性。濾紙常與測定蛋白質所需乏兮 ' ^ 而又忒劑X互反應,其程度太 於相同載體基材物質與測定其它分* 开匕刀析物質所需的組合物反 應之程度。 調整調配物以得到試劑組合物肖所用載體基材物質間均 一反應性的問題已是此範疇中的—個常久問題且是此項工 業中具有意義的重要性之-。起初,咸信調整試劑組合物 之pH値會克服試劑組合物與載體基材物質間反應變異性之 問題。但是,調整pH並未對所有各批載體基材物質皆有效 。需要的結果疋達成一種試劑组合物,此组合物會造成較 淡的陰性反應顏色及較深的陽性反應顏色。發現三通 (Triton) X-邮,一種聚乙烯界面活性劑,對反應性有較大的影 響,但是於顏色範圍的陰性反應及陽性反應端皆產生較淡 的顏色。 探查其它調整反應性之方法。例如,改變試劑組合物的 所有組份,但是未發現此種改變能有效產-生較淡的陰性反 應顏色及較深的陽性反應顏色。亦將聚乙醇引入試劑組合 物内並發現在控制不同批載體基材物質之試劑反應特性方 面無故。 因此,甚至是適當的定性控制,不同批載體基材物質間 嚐試實現有故的篩選以及發明限制反應性問題仍無法有效 控制。 (請先閲讀背面之注意事項再填寫本頁}This paper size applies the Chinese national standard (CNS > Λ4 specification (210X29 ^ J " J • 4-A7 B7) Ministry of Economic Affairs t Central Standards Bureau Staff Consumer Cooperative Cooperative Imprint V. Invention Description (2 It is obtained by the tendency to smoke urine samples The positive reading of protein. Another occurrence of this device structure is that if it is an absorbent material, it is usually a piece of paper, and the reagents used in the system are different. There is a constant (ie, uniform) Anti-reversibility. Filter paper often reacts with the protein required for the determination of ^ 'and tincture X, to the extent that the same carrier substrate material reacts with the composition required to measure other components. The problem of adjusting the formulation to obtain a uniform reactivity between the carrier substrate materials used in the reagent composition Xiao is already in this category-a long-standing problem and of great significance in this industry-. At first, Xianxin adjusted The pH of the reagent composition will overcome the problem of reaction variability between the reagent composition and the carrier substrate material. However, adjusting the pH is not effective for all batches of the carrier substrate material. The required results do not achieve one Reagent composition, this composition will cause a lighter negative reaction color and a darker positive reaction color. Triton X-mail, a polyethylene surfactant, was found to have a large effect on reactivity, but Both the negative reaction and the positive reaction end of the color range produce a lighter color. Explore other ways to adjust the reactivity. For example, change all the components of the reagent composition, but this change has not been found to effectively produce a lighter Negative reaction color and darker positive reaction color. Polyethanol was also introduced into the reagent composition and found no reason in controlling the reagent reaction characteristics of different batches of carrier substrate material. Therefore, even proper qualitative control, different batches of carrier substrate Inter-substance attempts to achieve sensible screening and invention to limit the reactivity problem still cannot be effectively controlled. (Please read the precautions on the back before filling this page}

本紙張尺度適用中國國家標準(CNS > Λ4規格(210 X 2W公缓) -5- Α7 Β7 I發明説明(3 ) 爲克服上述測定蛋白質之反應性問題’製備一種獨特的 試劑組合物’且以一種使試劑組合物與載體基材間之反應 變異性己大底排除之方法調配。此外,檢測結果上尿液pH 變異性之減少是此試劑组合物所見到的另一種效益。 發明之總論 本發明提供一種分析測試條以偵測生物樣品中之蛋白質 ,其包含一種酚碾酞蛋白質誤差指示劑,緩衝劑,及一種 其量等於或低於重量之百分之十的脂族聚碳酸酯。 依據本發明’使用吸收載體之二次浸潰試劑組合物步驟 ’其中缓衝液及視需要之染料如FD&C黃色#5及FD&C #3首先從水性溶液浸潰入吸收載體内,酚碾酞蛋白質誤 差指示劑及脂族聚碳酸酯化合物在第二次使用非水性溶劑 如醇溶液浸潰時浸入。 本發明另一個範圍係指偵測生物樣品中蛋白質的方法, 其中分析試紙條用生物樣品潤濕。潤濕的試紙條含有用如 上所述試劑組合物浸潰的吸收載體《觀察試紙條偵測任何 顏色改變,其是生物樣品中蛋白質存在及數量之指示。 較佳具體實例之説明 依據本發明,已發現可製備測定生物液體中蛋白質的測 試條而對不同批的載體基材無載體基材與試劑组合物間任 何明顯的反應性問題。此外,已發現尿液可變性對偵測極 限之影響,對眼觀偵測及儀器偵測皆因本發明試劑組合物 而減少。 本發明由試劑組合物浸溃吸收載雄基材達成。吸收性載 本紙張尺度適用中國國家橾準(CNS ) Α4规格(210Χ297公釐) -β7 ---,--Κ-----Ί-- (請先閲讀背面之注f項再填寫本頁) 訂 經濟部中央標準局貝工消费合作社印製 經濟部中央標準局貝工消費合作社印袋 A7 B7 五1發明説明(4 ) m基材以處紙較佳。較佳的遽紙是得自处1也〇瓜F此ati〇n inc 之級號204 »•其含木材及纖維漿混合物。濾紙各批不同。 篩選及發明限制過去在保證試劑最大功效方面已無效。 其它可作爲吸收性載體包括毛氈,有孔陶條以及織塊玻 璃纖維(述於美國專案第3,846,247號)。亦提出適於作試驗條 的適當吸收載體之物質如木材,布,海绵材料及黏土性材 料(如美國專利案第3,552,928號中所述)。但是,已發現,儘 管各批間存在差異,濾紙特別適用。 吸收性載體基材以上述方式浸潰試劑组合物。已發現 ,使用兩次浸入浸潰步驟,水溶液第一次浸潰及非水性溶 背J第二次浸漬,得到最佳結果。吸收條以含緩衝液以調整 pH至約1.5及4.5間較佳。系統以調節pH至約3·5較佳,以約 3.7最佳。但是並未嚴格規定緩衝液系統之性質。可使用所 有熟知的緩衝材料。缓衝液以包括檸檬酸及檸檬酸納較佳 Ο 若緩衝劑大於9.3公克/dl(每公合之公克數),試劑操作· 會是問題,若緩衝劑小於7.1公克/ d 1 .,緩衝劑可能不足。 以相當於8.7公克/dl.數量之緩衝劑最適當.。 除了緩衝劑物質外,視需要在第一次浸潰時添加紅色染 料及黃色染料。可使用任何適用於試劑組合物之紅色染_ 。但是,FD & C紅色# 3是較佳之材料。較佳黃色染料是 FD & C黃色# 5。染料於陰性反應顏色濃度時遮蓋住尿液 生色。其它的染料,界面活性劑等等亦可於第~次浸潰時 添加作爲額外的视需要組份。 本纸張尺度適用中國國家標隼(CNS ) Λ4規格(21〇Χ 2们公釐) (請先閱讀背面之注意事項再填寫本頁) ."--«I L-··-·—— I IP · -'9 經濟部中央標準局員工消费合作社印製 A7 _ B7 五、發明説明(5 ) 通常,染料可使用過量約40公克/ 100公升以及少於约6〇 公克/ 100公升。對四溴酴藍(TBPB),以50公克/100公升最 適當。 ' 第二次浸潰時,使用非水性溶劑溶液,以乙醇較佳,以 減少蒸發作用。可使用習用的多鹵化酚諷酞蛋白質誤差指 示劑作爲指示劑化合物。適當之物質包括: 3,4,5,6,-四溴酚諷酞(TBPSP); 3,,3 ” -二硝基-3,4,5,6,-四溴酚風酞(DNTB); 3,,3”-二溴-3, 4,5,6,-四溴酚颯酞(DBTB); 3',3”-二碘-3,4,5,6,-四溴酚砜酞(〇汀6); 3’,3”,5’,5"-四硝基_3,4,5,6,-四溪驗颯欧(-^丁3); 3’,3"-二亞硝基-5',5"-—溴紛-3,4,5,6,-四溴諷酞 (DNoHB); 3,,3,,-二碘- 5,,5,,-二亞硝基酚-3, 4,5,6,_四溴諷酞 (DIDNo); 3 ’,3 "-二硝基-5 ’,5”,3,4,5,6,-六溴酚風酞(〇ΝΗΒ),· 3 ’ - 硝基-5 ’,5 ” -二碘-3”,3,4,5,6 , ·五溴驗颯酞(NDIpB); 3,,3”-二碘二硝基紛-3, 455,6,_四溴颯酞 (DIDNTB); 3 ’,3 -二硝基-5 ’ ’ 5 ” -二溴-3,4,5,6,-四碘蚧酞 (DNDBTI); 3 ’,3 ”,5 ’,5 "-四氣-3,4,5,6,-四溴紛砜炚(TCTB); 3 ’,3 ’’,5 ’,5 "-四溴-3,4,5,6,_ 四破酚砜酞(TBTI); 3 ’,3 ”,5 ’,5 -四峨盼—3,4,5,6,-四溴颯酞(丁ιΤΒ); (請先閲讀背面之注意事項再填寫本頁)This paper scale applies Chinese national standards (CNS > Λ4 specification (210 X 2W public delay) -5- Α7 Β7 I invention description (3) To overcome the above-mentioned problem of measuring protein reactivity, 'prepare a unique reagent composition' and Prepared by a method that eliminates the reaction variability between the reagent composition and the carrier substrate. In addition, the reduction in urine pH variability on the test results is another benefit seen with this reagent composition. Discussion The present invention provides an analytical test strip for detecting proteins in biological samples, which includes a phenol phthaloprotein error indicator, a buffer, and an aliphatic polycarbonate having an amount equal to or less than ten percent by weight. According to the present invention, the "secondary impregnation reagent composition step using an absorbent carrier" wherein the buffer solution and optionally a dye such as FD & C yellow # 5 and FD & C # 3 are first impregnated into the absorbent carrier from an aqueous solution. The phenol phthaloprotein error indicator and the aliphatic polycarbonate compound are immersed during the second impregnation with a non-aqueous solvent such as an alcohol solution. Another scope of the present invention refers to the detection of A method of analyzing protein in a sample, wherein a test strip is analyzed with a biological sample. The wet test strip contains an absorbent carrier impregnated with the reagent composition as described above, "observing the test strip to detect any color change, which is An indication of the presence and amount of protein in a biological sample. Description of preferred specific examples According to the present invention, it has been found that test strips for the determination of proteins in biological fluids can be prepared without any difference between the carrier substrates of different batches and between the carrier substrate and the reagent composition. Obvious reactivity problem. In addition, it has been found that the influence of urine variability on the detection limit, the visual detection and instrument detection are reduced by the reagent composition of the present invention. The present invention is immersed and absorbed by the reagent composition. The male base material is achieved. The absorptive size of this paper is applicable to China National Standards (CNS) Α4 specifications (210 × 297 mm) -β7 ---,-K ----- Ί-- (Please read the note on the back first (Please fill in this page again for item f.) Order printed by the Central Standards Bureau of the Ministry of Economic Affairs of the Shelling Consumer Cooperative, and print the printed bags of the Central Standards Bureau of the Ministry of Economic Affairs of the Shelling Consumer Cooperative. A7 B7 5-1 Description of the invention Paper Obtained from the Department of Pharmacy F 204, Inc. grade 204 »• It contains a mixture of wood and fiber pulp. The filter paper is different from batch to batch. Screening and invention limits have been ineffective in the past to ensure the maximum efficacy of the reagents. Others can be used as absorption Sexual carriers include felts, perforated ceramic strips, and woven glass fibers (described in US Project No. 3,846,247). Materials suitable for the carrier of test strips such as wood, cloth, sponge materials and clay materials (such as Described in U.S. Patent No. 3,552,928). However, it has been found that filter paper is particularly suitable despite differences between batches. The absorbent carrier substrate impregnates the reagent composition in the manner described above. It has been found that two impregnations are used for impregnation In step, the aqueous solution was immersed for the first time and the non-aqueous soluble back was immersed for the second time to obtain the best results. The absorbent strip is preferably buffered to adjust the pH to between about 1.5 and 4.5. The system is preferably adjusted to a pH of about 3.5, and most preferably about 3.7. However, the nature of the buffer system is not strictly specified. All well-known cushioning materials can be used. The buffer solution preferably includes citric acid and sodium citrate. If the buffer is greater than 9.3 g / dl (g per gram), the operation of the reagent will be a problem. If the buffer is less than 7.1 g / d 1. May be insufficient. A buffer equivalent of 8.7 g / dl. Is most appropriate. In addition to the buffer material, red and yellow dyes are added as needed during the first dip. Any red dye suitable for the reagent composition can be used. However, FD & C Red # 3 is a better material. A preferred yellow dye is FD & C Yellow # 5. Dyes cover urine development at negative reaction color concentrations. Other dyes, surfactants, etc. can also be added as an additional optional component during the first immersion. This paper size is applicable to China National Standard (CNS) Λ4 specification (21〇 × 2mm) (Please read the precautions on the back before filling this page). &Quot;-«I L- ··-· — — I IP · -'9 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 _ B7 V. Description of Invention (5) Generally, the dye can be used in excess of about 40 g / 100 liters and less than about 60 g / 100 liters. For tetrabromopyrene blue (TBPB), 50 g / 100 liters is most suitable. '' For the second immersion, use a non-aqueous solvent solution, preferably ethanol, to reduce evaporation. A conventional polyhalogenated phenolphthalein protein error indicator may be used as the indicator compound. Suitable substances include: 3,4,5,6, -tetrabromophenolphthalein (TBPSP); 3,, 3 "-dinitro-3,4,5,6, -tetrabromophenol wind phthalide (DNTB) ; 3,, 3 ”-dibromo-3, 4,5,6, -tetrabromophenolphthalein (DBTB); 3 ', 3” -diiodo-3,4,5,6, -tetrabromophenolsulfone Phthalo (〇 汀 6); 3 ', 3 ", 5', 5 " -tetranitro_3,4,5,6, -Sixi test 飒 Europe (-^ 丁 3); 3 ', 3 "- Dinitroso-5 ', 5 " --- bromofen-3,4,5,6, -tetrabromophthalide (DNoHB); 3,, 3 ,,-diiodo-5,5,5, -di Nitrosol-3, 4,5,6, _tetrabromophthalide (DIDNo); 3 ', 3 " -dinitro-5', 5 ", 3,4,5,6, -hexabromo Phenolphthalein (〇ΝΗΒ), · 3 '-Nitro-5', 5 "-Diiodo-3", 3, 4, 5, 6 · Pentabromopyridine (NDIpB); 3, 3 " -Diiododinitro-3, 455,6, _tetrabromofluorphthalide (DIDNTB); 3 ', 3 -dinitro-5' '5 "-dibromo-3,4,5,6,- Tetraiodofluorenphthalide (DNDBTI); 3 ', 3 ”, 5', 5 " -tetrakis-3,4,5,6, -tetrabromosulfone hydrazone (TCTB); 3 ', 3' ', 5 ', 5 " -Tetrabromo-3,4,5,6, _ Tetrahydrophenol sulfone phthalide (TBTI); 3', 3 ”, 5 ', 5- Si-Epan—3,4,5,6, -tetrabromofluorphthalide (butyl ΤΒ); (Please read the precautions on the back before filling in this page)

、1T 本紙張尺度適用t國國家標準(CNS ) A4規格(210X297公釐) ~--:— A7 B7 五、發明説明(6 ) ,6,_四溴驗諷酞 3,,3 "-二磺酸基-5,,5,,_ 二氣—3,4,5 (DSDC); ' 戚政 (請先閲讀背面之注意事項再填寫本頁) 3,,3 "-二礓酸基_ 5,,5 "-二溴酚〜3 4 )’ 4,5,6,-四溴 (DSHB);, ’ 以四溴酚諷酞爲較佳物質。 第二次浸潰試劑組合物之其它基本成份是脂族聚乙醚_ 聚碳酸酯材料。利用二苯基碳酸酯以及二官能基羥基化合 物或二官能基輕基化合物之混合物製備。聚碳酸醋之説明 ,其分子量以及其製備中所用的醇列於下表中· 表 1 認明編號 醇化合物 _比例 分子量 ΚΟΚ 9209 四甘醇/ 1 1795 己二醇-1,6 1 ΚΟΚ 10,000 四甘醇/ 1 4187 己二醇-1,6 1 ΚΟΚ 10,001 三甘醇 - 1972 ΚΟΚ 10,002 三甘醇/ 1 1972 四乙醇 ΚΟΚ 10,071 聚醚L-950(聚丙二醇 - 1594 經濟部中央標準局員工消费合作社印裝 上表1中之最後一項物質特佳。此聚環氧丙烷碳酸酷 聚物,由聚乙醚L 950®物質[貝爾(Bayer)AG ]經丁氧化鈦 催化與具下外構造之碳酸二苯基酯縮合製得 本紙張尺度適用中國國家標準(CNS ) Λ4规格(210X297公釐) -9-、 1T This paper size is applicable to the national standard (CNS) A4 specification (210X297 mm) ~-: A7 B7 V. Description of the invention (6), 6, _ tetrabromophthalmide 3, 3 "- Disulfonic acid-5,, 5, __ Digas-3,4,5 (DSDC); 'Qi Zheng (Please read the precautions on the back before filling this page) 3 ,, 3 " -Diphosphonic acid _5,, 5 " -Dibromophenol ~ 3 4) '4,5,6, -Tetrabromo (DSHB) ;,' Tetrabromophenol is preferred. The other essential component of the second impregnation reagent composition is an aliphatic polyether-polycarbonate material. It is prepared using a mixture of diphenyl carbonate and a difunctional hydroxy compound or a difunctional light compound. The description of polycarbonate, its molecular weight and the alcohol used in its preparation are listed in the table below. Table 1 Identification of the numbered alcohol compound_ Proportion molecular weight ΚΟΚ 9209 Tetraethylene glycol / 1 1795 Hexanediol-1, 6 1 ΚΟΚ 10,000 Four Glycol / 1 4187 Hexanediol-1, 6 1 ΚΟΚ 10,001 Triethylene glycol-1972 ΚΟΚ 10,002 Triethylene glycol / 1 1972 Tetraethanol ΚΟΚ 10,071 Polyether L-950 (Polypropylene glycol-1594 Employee Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs The last substance listed in Table 1 is particularly good. This polypropylene oxide carbonic acid polymer is catalyzed by polyether L 950® substance [Bayer AG] with titanium dioxide but with carbonic acid with the following external structure. Diphenyl ester condensed to obtain the paper size applicable to the Chinese National Standard (CNS) Λ4 specification (210X297 mm) -9-

其中: η定義爲重複聚醚數,爲介於4至15之一整數,較佳介於 4 至 1 1 ; m定義爲重複聚碳酸數,爲介於1至之一整數,較佳 介於1至7,最佳介於1至5。 起始物質聚乙鍵L 950是一種二官能基之聚丙二醇,平均 分子量約420’由環氧丙烷在12-丙二醇之存在下聚合製 得。每個二醇殘基生出一個聚合鏈,造成一種線性聚合物 ’其各端以二級獲基終結(即’有兩個官能性之經基)。得 自聚乙醚殘基與碳酸酯連接的聚乙醚-聚碳酸酯物質具下 列比例: HI- In n^il It^〆 ei mu mt^ —HI— \OJ /St (請先閲讀背面之注意事項再填寫本頁) 聚乙醚L 950 碳酸二苯基酯 Ti(OC4H9)4 amt(公克) 4248 1581 0.6 amt(莫爾) 10.22 7.39 0.0018 經濟部中央標準局員工消費合作杜印製 已發現限制脂族聚乙醚-聚碳酸酯物質之量至10 %重量計 或更低對於減少比重效應具重要性。有關降低濾紙效應, 已發現宜於降低脂族聚乙醚聚碳酸酯物質之量至百分之 二以重量計或更低。 展示下列實例揭述較佳具體實例及本發明之用途,並不 意味限制本發明,除非在後附的申請專利範圍中另有説明 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -τστ A7 B7 經濟部中央標準局貝工消费合作社印製 五、發明説明(8 ) 實例1 A. 含具竣酸準—之試劑趣」及無聚合物之拄制試劑的製備 未經緩衝的蛋白質試劑與緩衝試驗溶液一起使用以認明 可用的·聚合物。 浸潰溶液:0.3mM四溴酚藍,TBPB,以及〇」%或丨〇0/〇 (w / v )聚碳酸醋之THF溶液。(控制試劑用相同的浸潰溶液 製備,其不含聚合物)。 利用速度4呎/分鐘及乾燥溫度60乇將浸漬液浸入華特曼 (Whatman)CCP-500紙内。試劑紙經處理成含〇 2 X 〇 2英吋墊之 試劑條。 B. 試劑反應性之測量 1. 樣品。試劑浸入0.20M擰檬酸鉀緩衝液,pH 3.5或4.0, 含或不含20毫克/dL人類血清白蛋白(HSA)。 2. 儀器讀値。試條浸潰於樣品中20秒後在CLINTEK® 200 儀器上測量於630毫微米(nm)(亦可使用610nm )之百分反 射比。依據方程式K/S = ( 1 - R)2/2R計算K/S。各數値 是10次重複測量値的平均値。 C. 結果及討論 - 1.數據。 (請先聞讀背面之注意事項再填寫本頁)Among them: η is defined as the number of repeated polyethers, which is an integer between 4 and 15, preferably between 4 and 1 1; m is defined as the number of repeated polycarbonates, which is an integer between 1 and 1, preferably between 1 and 7, preferably between 1 and 5. The starting material polyethylene bond L 950 is a difunctional polypropylene glycol having an average molecular weight of about 420 ', which is prepared by polymerizing propylene oxide in the presence of 12-propylene glycol. Each diol residue gives rise to a polymer chain, resulting in a linear polymer ′ whose ends are terminated with secondary radicals (that is, ′ has two functional radicals). The polyether-polycarbonate material obtained from the connection of polyether residues to carbonates has the following ratio: HI- In n ^ il It ^ 〆ei mu mt ^ —HI— \ OJ / St (Please read the precautions on the back first Refill this page) Polyether L 950 Diphenyl Carbonate Ti (OC4H9) 4 amt (g) 4248 1581 0.6 amt (Moore) 10.22 7.39 0.0018 The consumption cooperation of employees of the Central Standards Bureau of the Ministry of Economic Affairs has been found to restrict aliphatics. The amount of polyether-polycarbonate material to 10% by weight or less is important for reducing the specific gravity effect. Regarding the reduction of the filter paper effect, it has been found suitable to reduce the amount of the aliphatic polyether polycarbonate material to 2% by weight or less. The following examples are shown to disclose the preferred specific examples and the application of the present invention, which does not mean to limit the present invention, unless otherwise stated in the scope of the attached patent application. This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm). ) -Τστ A7 B7 Printed by the Shellfish Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (8) Example 1 A. Contains reagents with complete acidity— "and the preparation of polymer-free reagents without buffer Protein reagents are used with buffered test solutions to identify available polymers. Impregnation solution: 0.3 mM tetrabromophenol blue, TBPB, and 0 %% or 100/0 (w / v) solution of polycarbonate in THF. (Control reagents are prepared with the same impregnation solution, which is polymer-free). The impregnation solution was immersed in Whatman CCP-500 paper at a speed of 4 feet per minute and a drying temperature of 60 ° C. The reagent paper is processed into a reagent strip containing a 2 x 02 inch pad. B. Measurement of reagent reactivity 1. Sample. The reagent was immersed in 0.20M potassium citrate buffer, pH 3.5 or 4.0, with or without 20 mg / dL human serum albumin (HSA). 2. The instrument reads the sound. The test strip was immersed in the sample for 20 seconds and the percent reflectance was measured on a CLINTEK® 200 instrument at 630 nanometers (nm) (610 nm can also be used). Calculate K / S according to the equation K / S = (1-R) 2 / 2R. Each number is the average of 10 repeated measurements. C. Results and discussion-1. Data. (Please read the notes on the back before filling this page)

、1T 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210 X 297公釐) -11 - 五、發明説明(9 ) A7 B7 表2 : pH 3.5結果 於630nm,20s之K/S (標準偏差) 聚合物 無HSA 20毫克/dL HSA 斜度 空白組減 少之%⑴ 斜度減少%(2) None 0.088 0.375 0.0144 - - (.005) (.020) ΚΟΚ 9209 0.068 0.271 0.0102 56 29 (0.1% W/V) (.007) (.008) ΚΟΚ 10,000 0.079 0.283 0.0102 25 29 (0.1% W/V) (.002) (.008) ΚΟΚ 10,000 0.069 0.229 0.0080 53 44 (1.0% W/V) (.002) (.007) ΚΟΚ 10,001 0.077 0.322 0.0123 31 15 (0.1% W/V) (.003) (.018) ΚΟΚ 10,002 0.071 0.327 0.0128 47 11 (0.1% W/V) (.006) (.008) 經濟部中央標準局員工消費合作社印裝 (1) 已發現空白紙的K / S約爲0.052 ;因此。/〇空白組減低-[U空白組:無聚合物之κ^-0.052)-(空白組:有聚合 物之K/S-0.052 ) } / (空白组:無聚合物之K/S-0.052 ) ] X 100 . (2) %傾斜度減少=[(無聚合物之斜度-具聚合物之斜度 )/(無聚合物之斜度)]X 1〇〇 於pH 4.0得到類似結果。 2.討論。緩衝溶液中,pH 3.5及4.0,一些聚碳酸酯減低空 白組甚於減低斜度。自本實驗中已經認爲添加聚碳酸 酯至完整的蛋白質試劑(皆含緩衝劑及TBPB )内會降低 (請先閲讀背面之注意事項再填寫本頁)、 1T This paper size applies the Chinese National Standard (CNS) Λ4 specification (210 X 297 mm) -11-V. Description of the invention (9) A7 B7 Table 2: pH 3.5 results at 630nm, 20s K / S (standard deviation) ) Polymer-free HSA 20 mg / dL HSA% decrease in slope blank group %% decrease in slope (2) None 0.088 0.375 0.0144--(.005) (.020) ΚΟΚ 9209 0.068 0.271 0.0102 56 29 (0.1% W / V) (.007) (.008) ΚΟΚ 10,000 0.079 0.283 0.0102 25 29 (0.1% W / V) (.002) (.008) ΚΟΚ 10,000 0.069 0.229 0.0080 53 44 (1.0% W / V) (.002 ) (.007) ΚΟΚ 10,001 0.077 0.322 0.0123 31 15 (0.1% W / V) (.003) (.018) ΚΟΚ 10,002 0.071 0.327 0.0128 47 11 (0.1% W / V) (.006) (.008) Economy Printed by the Consumer Standards Cooperative of the Central Bureau of Standards (1) K / S of blank paper has been found to be approximately 0.052; therefore. / 〇 Blank group reduced-[U blank group: κ ^ -0.052 without polymer]-(blank group: K / S-0.052 with polymer)} / (blank group: K / S-0.052 without polymer )] X 100. (2)% slope reduction = [(slope without polymer-slope with polymer) / (slope without polymer)] X 100 obtained similar results at pH 4.0. 2. Discussion. In the buffer solution, at pH 3.5 and 4.0, some polycarbonates reduced the white group more than the slope. Since this experiment, it has been thought that adding polycarbonate to the intact protein reagent (both containing buffer and TBPB) will decrease (please read the precautions on the back before filling this page)

本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -12- 經濟部t夬揉芈局属工消费合作社印装 A7 B7 五、發明説明(10 ) 初色(空白组),可能減低錯誤陽性之發生率。 實例2 A. Jggg_i〇〇/0 κ〇κ 10.071蛋白皙試劑調配物 1.緩衝貯液溶液》溶解14.75公克檸檬酸,10.93公克檸檬 酸鈉’以及7·2毫克FD&C黃色#5於154毫升蒸餾水中 ;pH = 3.46。 2第一次浸潰液。⑻17.94公克緩衝貯液溶液;(b)5.0公克 乙醇及(c)2.47公克蒸餾水。 3.第二次浸潰液。(a) 7 5毫克TPBP ;⑼2 5公克K〇K1〇 〇71 及(c)用THF適量加至25毫升。 B. J第一次浸清液及第二次浸清液製備控制組調配物,其 未含聚合物。 以每分鐘4呎之速度將浸潰液浸入E&D 237C紙,第一次 浸漬之乾燥溫度爲80 °C,第二次浸潰溫度爲60 。 C. 試劑反應性之測量 1.樣品。試驗樣品爲⑴陰性反應基質SG尿液池及HSA倒 入基質SG尿液池内以得到濃度15毫克/ d L,以及(2)三 種臨床陰性1反應高SG尿液樣品(SG=A4.028 ; B,1.027 ; 以及C,l.〇27 )。於CLINK® 200儀器上測量三種樣品之反 應性(每種樣品重複3次)。_ 1臨床陰性反應由沙弗沙(Sulfosal)試驗定義爲陰性。含HSA S2毫克/dL,總蛋白質<10毫克/dL。目的是爲臨床陰性 尿液得到反應。此尿液由15毫克/dL HSA得少部份反應。 本紙張尺度逍用中困國家揉準(CNS ) A4规格(210X297公釐) -1T- (請先閲讀背面之注意事項再填寫本頁) 訂 A7 B7 '* 五、發明説明(11) 2.下列數據顯示爲各樣品之Κ/S値。此外,由各高SG尿 液樣品之貢獻以[(K/S高sg_K/S空白組)/ ( K/S umg/dL· Κ/S空白组)]X 1〇〇。此貫獻値是由高SG尿液所引起的 15毫克/dL HSA之百分比。 I l·——— ^—n I— Is I I T t (請先閲讀背面之注意Ϋ項再填寫本頁)This paper size is applicable to Chinese National Standard (CNS) A4 (210X297 mm) -12- Printed by the Ministry of Economic Affairs, Industrial and Consumer Cooperatives A7 B7 V. Description of the invention (10) Initial color (blank group), May reduce the incidence of false positives. Example 2 A. Jggg_i〇〇 / 0 κ〇κ 10.071 protein reagent formulation 1. Buffer stock solution> Dissolve 14.75 grams of citric acid, 10.93 grams of sodium citrate 'and 7.2 mg FD & C yellow # 5 in 154 Ml of distilled water; pH = 3.46. 2 The first dipping solution. ⑻17.94 grams of buffered stock solution; (b) 5.0 grams of ethanol and (c) 2.47 grams of distilled water. 3. The second dipping solution. (A) 75 mg of TPBP; 25 g of KOK 10071 and (c) add an appropriate amount of THF to 25 ml. B. J. The first lysate and the second lysate prepared the control group formulation, which contained no polymer. The impregnation solution was dipped into E & D 237C paper at a rate of 4 feet per minute. The drying temperature for the first impregnation was 80 ° C, and the temperature for the second impregnation was 60 ° C. C. Measurement of reagent reactivity 1. Sample. The test samples were ⑴ negative reaction matrix SG urine pool and HSA was poured into the matrix SG urine pool to obtain a concentration of 15 mg / d L, and (2) three clinically negative 1 response high SG urine samples (SG = A4.028; B, 1.027; and C, 1.027). The reactivity of three samples was measured on a CLINK® 200 instrument (3 replicates for each sample). _ 1 A clinical negative reaction is defined as negative by the Sulfosal test. Contains HSA S2 mg / dL, total protein < 10 mg / dL. The goal is to get a response for clinically negative urine. This urine responded to a small fraction of 15 mg / dL HSA. Standards for this paper Standards for use in poor countries (CNS) A4 (210X297 mm) -1T- (Please read the precautions on the back before filling this page) Order A7 B7 '* V. Description of the invention (11) 2. The following data are shown as K / S 値 for each sample. In addition, the contribution of each high SG urine sample is [(K / S high sg_K / S blank group) / (K / S umg / dL · K / S blank group)] X 100. This continuation is a percentage of 15 mg / dL HSA caused by high SG urine. I l · ——— ^ —n I— Is I I T t (Please read the note on the back before filling this page)

經濟部中央搮準局負工消费合作社印SL 對HSA之初色及反應性皆因10% ΚΟΚ 10,071減低。但是, 亦降低陰性反應高SG尿液之貢獻値頗多。因此,10% ΚΟΚ 10,071聚合物之存在顯然降低高SG尿液樣品得到錯誤陽性 結果之可能性* 其它實例比較具有及不具有4 % ΚΟΚ 10,071之含TBPB之蛋 白質試劑。 實例3 Α.ΤΒΡΒ-ΚΟΚ蛋白皙試劑調配物(其量足以製備100毫升浸潰 液) 1_第一次浸渍液(0.45Μ檸檬酸鈉-pH 3.70,0.03mM FD & C 黃色;水溶液)。(a) 50毫升〇·9 Μ檸檬酸鈉-pH 3.70 ; 表3 10%KOK10,071對蛋白質試劑功效的效應 於630mn之Κ/S(標準偏差) 基質SG尿液 高SG尿液 高SG尿液貢獻値The initial color and responsivity of the printed SL to the HSA by the Central Workstation Consumer Cooperative Bureau of the Ministry of Economic Affairs was reduced by 10% ΚΟΚ 10,071. However, the contribution of high SG urine that also reduces negative reactions is considerable. Therefore, the presence of 10% KOK 10,071 polymer significantly reduces the possibility of false positive results in high-SG urine samples. * Other examples compare TBPB-containing protein reagents with and without 4% KOK 10,071. Example 3 ΑΒΤΒΒ-ΚΟΚ protein reagent formulation (the amount is sufficient to prepare 100 ml infusion) 1_ the first infusion (0.45M sodium citrate-pH 3.70, 0.03mM FD & C yellow; aqueous solution) . (A) 50 ml of 0.9M sodium citrate-pH 3.70; Table 3 Effect of 10% KOK10,071 on protein reagent efficacy at K / S (standard deviation) of 630mn Matrix SG urine high SG urine high SG urine Liquid contribution

試劑 15毫克/dL 無HSA HSA A B C A 旦 C 無聚合物 0.165 (.016) 0.29 (.013) 0.258 (.012) 0.238 (.017) 0.240 (019) 74 58 60 10% κοκ 10,071 0.073 (005) 0.137 (.002) 0.088 (013) 0.092 (.004) 0.086 (OH) 23 30 20 本纸法纽t H S家樑準(〇^)戍4«1^(210父297公釐) "14 ' 經濟部中央標準局員工消费合作社印焚 A7 B7五、發明説明(12 ) (b) 3.0毫升ImM FD & C黃色# 5號;及(c) 47毫升蒸餾水 Ο - 2.第二次浸潰液(0.30mM TBPB,4%(W/V)KOK 10,071 ;於 THF 中) 。⑷ 30 毫升 ImM TBPB 之 THF 溶液;(b) 40 毫升 10% ΚΟΚ 10,071之THF溶液;以及(c) 30毫升THF。 用第一次浸潰液及第二次浸潰液製備控制组調配物,其 未含聚合物。浸潰液浸入如實例π之Ε & D 237C紙。 Β.試劑反應性之測量 1.樣品。基質SG尿液中試樣如上述倒入HSA。使用具有 臨床陰性反應高SG尿液(A ; SG = 1.030 ; pH = 5.6 )及一 種經過設計的鹼性高SG尿液池(B ; SG = 1.024 ; pH = 8.7 ) 測試可能的錯誤陽性讀値。使用高SG尿液” B ”作爲”不 佳案例”實例以測試ΚΟΚ聚合物效應之限制。於 CLINITEK® 200 +儀器上測量各樣品之反應性重複6次, 數據如下所示: 表4 4% ΚΟΚ 10,071對蛋白質試劑功效的效應 於630 nm之K/S (標準偏差具90 %可信度) (請先閲讀背面之注意事項再填寫本頁)Reagent 15 mg / dL without HSA HSA ABCA denier C without polymer 0.165 (.016) 0.29 (.013) 0.258 (.012) 0.238 (.017) 0.240 (019) 74 58 60 10% κοκ 10,071 0.073 (005) 0.137 (.002) 0.088 (013) 0.092 (.004) 0.086 (OH) 23 30 20 Paper New Zealand t HS Jia Liang Zhun (〇 ^) 戍 4 «1 ^ (210 father 297 mm) " 14 'Economy Ministry of Standards Bureau Consumers' Co-operative Printing A7 B7 V. Invention Description (12) (b) 3.0 ml ImM FD & C Yellow # 5; and (c) 47 ml distilled water 〇-2. The second dipping solution (0.30 mM TBPB, 4% (W / V) KOK 10,071; in THF). ⑷ 30 ml of a solution of 1 mM TBPB in THF; (b) 40 ml of a 10% solution of KOKK 10,071 in THF; and (c) 30 ml of THF. Control group formulations were prepared using the first impregnation solution and the second impregnation solution, which contained no polymer. The impregnating solution was immersed in E & D 237C paper as in Example π. Β. Measurement of reagent reactivity 1. Sample. Samples of matrix SG urine were poured into HSA as described above. Highly SG urine with clinical negative response (A; SG = 1.030; pH = 5.6) and a designed alkaline high SG urine pool (B; SG = 1.024; pH = 8.7) are tested for possible false positive readings . High SG urine "B" was used as an example of "bad case" to test the limitation of the KOK polymer effect. The reactivity of each sample was measured 6 times on a CLINITEK® 200+ instrument. The data are shown below: Table 4 Effect of 4% ΚΟΚ 10,071 on the efficacy of protein reagents at K / S at 630 nm (standard deviation with 90% confidence ) (Please read the notes on the back before filling this page)

,1T 基質SG尿液 高SG尿液 高SG尿液貢獻値 試劑 15毫克/dL_ 無HSA HSA A 旦 A 旦 無聚合物 0.268 (.012) 0.458 (.023) 0.379 (ΟΠ) 0.430 (.023) 58 85 4% ΚΟΚ 10,071 0.110 (.002) 0.241 (.007) 0.145 (.004) 0177 (.004) 26 51 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐) -15- 經濟部中央標準局員工消费合作社印裝 Α7 Β7 五、發明説明(13 ) 第一個貫例中,對HSA之初色及反應性皆因κοκ 10,071減 低。同樣的-,相對於無聚碳酸酯之試劑,亦降低陰性反應 高SG尿液f貢獻。此證實聚碳酸酯降低高SG尿液樣品得 到錯誤陽性結果之可能性。 ’ 實例4 水溶液(10公升),調整至pH 3 7,具有417公克檸檬酸鈉 ’ 455公克檸檬故’ 〇·29公克fd&C黃色#5及0.5公克FD& C紅色井3以及使用24公克PVA浸潰濾紙等級204C。 第一次浸潰(溫度80-100。(:)後,濾紙用第二種溶液浸潰。 第二種溶液(10公升)是5公克四溴酚颯酞之乙醇溶液,5〇 公克檸檬酸及150公克環氧丙烷碳酸酯共聚物[由經過丁氧 化鈇(IV)催化縮合的L 95〇@貝爾(Bayer)AG ]與碳酸二苯基醋 製得。然後所得物質於溫度35至1〇5。(:乾燥。 實例5 僅在果漿批次不同的紙,當與無K〇K之蛋白質試劑使用 時,會引起反應性大不同(表5)。已提出染料及蛋白質對 紙纖維結合的差異引起批次間差異。此外,已經提出染料 與紙結合性之增加會增加檢測的背景,蛋白質與紙結合性 之增加會減少檢測的蛋白質反應。表5以使用類似於實例4 之中心處方無ΚΟΚ得來。 本紙张尺度通用令國國家構华(CNS ) Λ4規格(2 ] 〇 χ 297公釐) -16- ----„-----^--r-L--r -------------訂----------Γ Mn f . (請先閲讀背面之注意事項再填寫本頁) 五、發明説明(彳4 ) A7 B7 表5 經濟部中央標隼局員工消费合作社印策 CLINITEX-10 CLINITEX-200 等級 批次 陰性 平均値 陽性 平均値 陰性 平均値^ 陽性 平均値 237 7775 672 525 695 479背景最少 237 8079 745 549 824 511 237 8137 753 560 839 529 237 14014 706 551 743 510 237 8977 743 586 800 572 237 9241 740 595 787 555 237 9041 - - 761 570 204 331 749 555 838 525 204 225 772 578 866 545背景最大 204 342 760 562 850 523 204 14011 755 575 818 548 204 14013 759 584 823 555 204 306 740 563 805 537 204 238 767 595 841 . 564 204 9115 _ 一 839 572 對兩種不同的麥爾氏(Miles’)儀器,CLINITEK -10及CLINITEK -200,試劑反應性以解碼數字表示。解碼數字根據610至 660nm處最大吸收的百分反射度而定。解碼數字低顯示反 應性高以及背景顏色較多。此些測定之試劑pH値爲3.46。 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210Χ297公酱) -17- (請先閱讀背面之注意事項再填寫本頁), 1T matrix SG urine high SG urine high SG urine contribution 値 reagent 15mg / dL_ no HSA HSA A denier A denier polymer 0.268 (.012) 0.458 (.023) 0.379 (〇Π) 0.430 (.023) 58 85 4% ΚΟΚ 10,071 0.110 (.002) 0.241 (.007) 0.145 (.004) 0177 (.004) 26 51 This paper size applies to the Chinese National Standard (CNS) Λ4 specification (210X297 mm) -15- Ministry of Economic Affairs Printed by the Consumer Standards Cooperative of the Central Bureau of Standards A7 B7 V. Description of Invention (13) In the first example, the initial color and reactivity to HSA were all reduced by κοκ 10,071. Similarly-compared to reagents without polycarbonate, it also reduces negative reactions with high SG urine f contribution. This confirms that polycarbonate reduces the likelihood of false positive results in high-SG urine samples. 'Example 4 Aqueous solution (10 liters), adjusted to pH 3 7, with 417 grams of sodium citrate' 455 grams of lemon so '〇29 grams of fd & C yellow # 5 and 0.5 grams of FD & C red well 3 and using 24 grams PVA impregnated filter paper grade 204C. After the first impregnation (temperature 80-100. (:), the filter paper was impregnated with a second solution. The second solution (10 liters) was a solution of 5 grams of tetrabromophenolphthalein in ethanol and 50 grams of citric acid. And 150 grams of propylene oxide carbonate copolymer [from L 95〇 @ Bayer (AG) catalyzed by osmium (IV) butyl oxide] and diphenyl carbonate. Then the obtained material is at a temperature of 35 to 10. 5. (: Drying. Example 5 Only in different pulp pulp batches, when used with KOK-free protein reagents, it will cause a large difference in reactivity (Table 5). It has been proposed that dyes and proteins bind to paper fibers Differences between batches lead to differences between batches. In addition, it has been proposed that an increase in the binding of dye to paper will increase the background of the test, and an increase in the binding of protein to paper will reduce the protein response of the test. Table 5 uses a central prescription similar to Example 4 Available without ΟΟΚ. The paper size is generally made by the country's national structure (CNS) Λ4 size (2) 〇χ 297 mm -16- ---- „----- ^-rL--r- ----------- Order ---------- Γ Mn f. (Please read the notes on the back before filling in this page) V. Invention (彳 4) A7 B7 Table 5 Employees ’Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs of the People ’s Republic of China CLINITEX-10 CLINITEX-200 Grade Batch Negative Average 値 Positive Average 値 Negative Average 値 Positive Average 値 237 7775 672 525 695 479 Background minimum 237 8079 745 549 824 511 237 8137 753 560 839 529 237 14014 706 551 743 510 237 8977 743 586 800 572 237 9241 740 595 787 555 237 9041--761 570 204 331 749 555 838 525 204 225 772 578 866 545 background maximum 204 342 760 562 850 523 204 14011 755 575 818 548 204 14013 759 584 823 555 204 306 740 563 805 537 204 238 767 595 841. 564 204 9115 _ one 839 572 For two different Miles' instruments, CLINITEK -10 and CLINITEK -200, the reagent reactivity is represented by the decoded number. The decoded number is determined by the percent reflectance of the maximum absorption at 610 to 660nm. A low decoded number indicates high reactivity and a large background color. The pH of these reagents was 3.46. This paper size applies to Chinese National Standard (CNS) Λ4 specification (210 × 297 male sauce) -17- (Please read the precautions on the back before filling this page)

,1T 經濟部中央標準局員工消費合作社印策 393578 A7 _ B7 五、發明説明(15) 237 與 2〇4 濾紙等級爲 Alhstrom Filtration of Mt.Holly Springs,賓州 O , 依據實例4所製得之分析測試條用尿液弄濕,觀察所得 顏色改變,i己錄爲尿液生物樣品中蛋白質之指示。 如表6中所見,蛋白質4試劑"Pr〇 4”(依據實例4 )已大大 減低爐紙批次效應。此種降低作用增加可製造性,使得試 劑結果稱一致。聚合物被認爲因破壞染料與木質纖維之結 合而減低濾紙變異性。結果,蛋白質試劑反應性可在一個 目標上保持一致性。 表6 反應性, 1T Consumer Policy Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs of the PRC 393578 A7 _ B7 V. Description of the invention (15) 237 and 204 The grade of filter paper is Alhstrom Filtration of Mt. Holly Springs, O, Pennsylvania. Analyze the test strips with urine and observe the resulting color changes. I has been recorded as an indicator of the protein in the urine biological sample. As can be seen in Table 6, the protein 4 reagent " Pr04 " (based on Example 4) has greatly reduced the furnace paper batch effect. This reduction effect increases manufacturability and makes the reagent results consistent. Polymers are considered due to Destroy the combination of dye and wood fiber to reduce filter paper variability. As a result, protein reagent reactivity can be consistent on one target. Table 6 Reactivity

處方 陰性 30毫克/dLPrescription negative 30 mg / dL

Pro 4 883 570 863 570 904 586 已經發現’甚至使用不同批滤紙,在料定蛋白質時,試 劑組合物與濾紙間之反應性不是一個因素。此外,關於不 同屎液樣品對眼觀及儀器偵測限制顯示試條變異性降低。 此與其它用於測試蛋白質的調配物相反,後者中,基質的 偵刺限制以及高比重尿液,眼觀及儀器讀値皆常改變。 雖然本發明容許各種修正及另一種形式,利用實例已顯 本纸張尺度適用中國國家標率(CNS ) Λ4規格(210X297公釐) -18- (請先閱讀背面之注意事項再填寫本頁) ------訂-----------Γ-. 393578 at B7 五、發明説明(16 ) 示其特定具體實例並已詳述。但是,應了解,此等實例無 意限制本發碉於所述特定形式,但是反之,本發明涵蓋所 有落於所附申請專利範圍定義的精神及範圍内的修正物, 相當物及可選擇之物。 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消费合作社印製 -19- 本紙張尺度適用中國國家橾準(CNS ) A4規格(210X297公釐)Pro 4 883 570 863 570 904 586 has been found that even when using different batches of filter paper, the reactivity between the reagent composition and the filter paper is not a factor when determining protein. In addition, eye and instrument detection limits on different fecal fluid samples showed reduced test strip variability. This is in contrast to other formulations used to test proteins, in which the detection limit of the matrix and the high specific gravity urine, vision and instrument readings are often changed. Although the present invention allows various corrections and another form, the application examples have shown that the paper size is applicable to the Chinese National Standard (CNS) Λ4 specification (210X297 mm) -18- (Please read the precautions on the back before filling this page) ------ Order ----------- Γ-. 393578 at B7 V. Description of the Invention (16) shows specific examples and has been detailed. However, it should be understood that these examples are not intended to limit the invention to the particular form described, but on the contrary, the present invention covers all amendments, equivalents, and alternatives falling within the spirit and scope defined by the scope of the appended patent application. . (Please read the precautions on the back before filling out this page) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs -19- This paper size applies to China National Standard (CNS) A4 (210X297 mm)

Claims (1)

10. 第84100273號專利申請1 中文申請專利範園修正, (8!年f〇月$ 告本 六、申請專利範圍 393578 1. 一種於生物樣品中測定蛋白質的檢測裝置,包含以下 列浸潰之吸收性的載體基材: ——種多齒化酚砜酞蛋白質誤差指示劑, 種緩衝劑,其加入係為調整ρ Η值至1 . 5及4.5間, 及 種脂族聚酸-聚碳酸酯,其量為〇 〇 1 %至1 〇 % (重 量/體積比)減少比重效應,且具有下列構造:10. Patent Application No. 84100273 1 Amendment to the Chinese Patent Application, (8! F0 $$ Announcement VI. Application Patent 393578 1. A detection device for measuring protein in biological samples, including the following immersion Absorptive carrier substrate: —— a kind of polydentified phenol sulfone phthaloprotein error indicator, a kind of buffer, which is added to adjust the ρ ρ value to between 1.5 and 4.5, and an aliphatic polyacid-polycarbonate Esters in an amount of 0.001% to 10% (weight / volume ratio) reducing specific gravity effect and having the following structure: 其中: η為介於4至15之一整數;及 m為介於1至1〇之一整數。 2. 根據中請專利範圍第1項之試驗裝置,其中多南化㈣ S太蛋白誤差指示劑為四溴碟盼自太。 經濟部中央標準局員工消費合作社印裝 (請先聞讀背面之注意事項再填寫本頁) 3. ,據申請專利範圍第i項之檢測裝置,其中脂族聚謎· 聚碳酸酯之存在量為〇 · 〇丨%至2 %(重量/體積比卜 4. 根據中請專利範圍第丨項之試驗裝置,其中η為介於*至 I 1 ’ m為介於1至7。 5·根據申請專利範圍第4項之檢測裝置,其中n為介於4至 II ’及m為介於1至5。 -1 - (CNS} (2l0x297^)-------- 10. 第84100273號專利申請1 中文申請專利範園修正, (8!年f〇月$ 告本 六、申請專利範圍 393578 1. 一種於生物樣品中測定蛋白質的檢測裝置,包含以下 列浸潰之吸收性的載體基材: ——種多齒化酚砜酞蛋白質誤差指示劑, 種緩衝劑,其加入係為調整ρ Η值至1 . 5及4.5間, 及 種脂族聚酸-聚碳酸酯,其量為〇 〇 1 %至1 〇 % (重 量/體積比)減少比重效應,且具有下列構造:Where: η is an integer between 4 and 15; and m is an integer between 1 and 10. 2. According to the test device in the scope of patent application No. 1, in which the donanized peptone S too protein error indicator is tetrabromopansulfan. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) 3. According to the testing device of the scope of application for patent i, the aliphatic polymystery and the amount of polycarbonate 0% to 2% (weight / volume ratio) 4. According to the test device of the patent claim, wherein η is between * and I 1 'm is between 1 and 7. 5 · According to The detection device under the scope of patent application No. 4 wherein n is between 4 and II ′ and m is between 1 and 5. -1-(CNS) (2l0x297 ^) -------- 10. Article 84100273 Patent Application No. 1 Chinese Application for Patent Garden Amendment, (8! F0 $$ Announcement 6. Application Patent Range 393578 1. A detection device for measuring protein in biological samples, including the following immersed absorbent carriers Substrate: —— a kind of polydentified phenol sulfone phthaloprotein protein error indicator, a kind of buffer, which is added to adjust the ρ Η value to between 1.5 and 4.5, and an aliphatic polyacid-polycarbonate, the amount It is 0.001% to 10% (weight / volume ratio) to reduce the specific gravity effect, and has the following structure: 其中: η為介於4至15之一整數;及 m為介於1至1〇之一整數。 2. 根據中請專利範圍第1項之試驗裝置,其中多南化㈣ S太蛋白誤差指示劑為四溴碟盼自太。 經濟部中央標準局員工消費合作社印裝 (請先聞讀背面之注意事項再填寫本頁) 3. ,據申請專利範圍第i項之檢測裝置,其中脂族聚謎· 聚碳酸酯之存在量為〇 · 〇丨%至2 %(重量/體積比卜 4. 根據中請專利範圍第丨項之試驗裝置,其中η為介於*至 I 1 ’ m為介於1至7。 5·根據申請專利範圍第4項之檢測裝置,其中n為介於4至 II ’及m為介於1至5。 -1 - (CNS} (2l0x297^)-------- A8 B8 C8 D8 申請專利範圍 6’驟種生物樣品中偵測蛋白質之方法,此法包含下列步 ⑷使用生物樣品弄濕分析測試條’測試條包括浸潰有 第-種水性浸潰液與緩衝劑的吸收性載體基材,然 後用。—種多4化酚概蛋白質誤差指示劑及0.01% 至】0%(重量//體積比)的脂族聚鍵-聚碳酸醋之非水 性溶劑溶液浸潰該吸收性的載體基材,以及; ()觀’Τ'並”己錄測試條之任何顏色改變,其中顏色變化 可作為該生物樣品中,蛋白質之指標; 其中•亥緩衝劑加入係為調整Ρ Η值至丨5至4.5間,及該 月印族4醚-聚碳酸酯之存在量為〇〇1%至1〇%(重量,體 積比)以減少比重效應,且具有下列構造: :--.----β —— (請先Μ讀背面之注$項存填θ育) 灯 ΗWhere: η is an integer between 4 and 15; and m is an integer between 1 and 10. 2. According to the test device in the scope of patent application No. 1, in which the donanized peptone S too protein error indicator is tetrabromopansulfan. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) 3. According to the testing device of the scope of application for patent i, the aliphatic polymystery and the amount of polycarbonate 0% to 2% (weight / volume ratio) 4. According to the test device of the patent claim, wherein η is between * and I 1 'm is between 1 and 7. 5 · According to The detection device under the scope of patent application No. 4 wherein n is between 4 and II ′ and m is between 1 and 5. -1-(CNS) (2l0x297 ^) -------- A8 B8 C8 D8 Patent application scope 6 'Method for detecting protein in a biological sample, this method includes the following steps: Wetting the analysis test strip with a biological sample' The test strip includes an absorbent impregnated with a first aqueous infusion and a buffer The carrier substrate is then impregnated with a non-aqueous solvent solution of a polyphenol-polycarbonate, a polyhydric phenolic protein error indicator, and 0.01% to 0% (weight // volume ratio). (1) any color change of the recorded test strip, where the color change may be As an indicator of the protein in the biological sample, the addition of the buffer is to adjust the pH value to between 5 and 4.5, and the presence of the Indian 4 ether-polycarbonate is 0.001% to 1 〇% (weight, volume ratio) to reduce the effect of specific gravity, and has the following structure: --.---- β —— (please read the first $ entry on the back and write θ education) π為介於4至丨5之—整數;及 m為介於1至1〇之一整數。 經濟部中央榇率局貝工消費合作社印製 其中: 根據申請專利範圍第6項之方法,其中該多齒化酚颯酞 蛋白質誤差指示劑為四溴颯酚酞。 根據申請專利範圍第6項之方法,其中脂族聚醚-聚碳 酸酷 < 存在量為〇 . 0 1 %至2 % (重量/體積比)。 (21。讀公着- 393578 i D8 六、申請專利範圍 申m申及據 ,據, 艮 1 艮 1 11 ιί. 1Α .0· On 1 範至範 第圍 法 方 之 項 至 4 於 介為 η中 其 m 於 第 ' ' 5圍至 法 方 之 項 至 4 於 介為 η中 其 ---------^—— * * (請先聞讀背面之注意事項再本頁) 訂 線 經濟部中央標準局員工消費合作社印製 本紙浪尺度適用中國國家標準(CNS ) A4規格(210X297公釐)π is an integer between 4 and 5; and m is an integer between 1 and 10. Printed by the Shellfish Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economics Among them: According to the method in the scope of patent application No. 6, wherein the polydentate phenol phthalate protein error indicator is tetrabromo phenol phthalide. The method according to item 6 of the application, wherein the aliphatic polyether-polycarbonate is present in an amount of from 0.01% to 2% (weight / volume ratio). (21. Reading public works-393578 i D8 VI. Application for patent application scope and data, according to, Gen 1 Gen 1 11 ιί. 1 Α .0 · On 1 Fan to Fan Di encircled law to 4 Yu Jiewei The m in η is the item from the 5th to the French side to 4 and the 4 in Jiewei η --------- ^ —— * * (Please read the precautions on the back before this page) The standard of printed paper waves printed by employees of the Central Standards Bureau of the Ministry of Economic Affairs of the Consumer Cooperative is applicable to the Chinese National Standard (CNS) A4 (210X297 mm)
TW84100273A 1995-01-13 1995-01-13 A test device and method for the determination of protein in a biological sample TW393578B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW84100273A TW393578B (en) 1995-01-13 1995-01-13 A test device and method for the determination of protein in a biological sample

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW84100273A TW393578B (en) 1995-01-13 1995-01-13 A test device and method for the determination of protein in a biological sample

Publications (1)

Publication Number Publication Date
TW393578B true TW393578B (en) 2000-06-11

Family

ID=21624766

Family Applications (1)

Application Number Title Priority Date Filing Date
TW84100273A TW393578B (en) 1995-01-13 1995-01-13 A test device and method for the determination of protein in a biological sample

Country Status (1)

Country Link
TW (1) TW393578B (en)

Similar Documents

Publication Publication Date Title
EP0799896B1 (en) Reagent test strip for determination of blood glucose
EP0800082B1 (en) Reagent test strip for blood glucose determination
JP3667370B2 (en) Method for measuring proteins in biological samples
JP3342077B2 (en) Improved oxidative coupling dyes for spectrophotometric determination of analytes
JP3219874B2 (en) Improved compositions and test devices for urine protein assays and methods of using the same
JP4576499B2 (en) Protein measurement method
CN1421700A (en) Method and apparatus for measuring concentration of analyte
JPH10505675A (en) Optically readable strip for analyte detection with on-strip orientation index
US5096833A (en) Method and device for determining protein using carrier matrix composed of urethane, water insouble inorganic compound and insoluble organic compound and method of making the device
TW382063B (en) Improved method for the detection of protein in urine
EP1810036A1 (en) Colorimetric strip containing coomassie blue for semi-quantitation of albumin
TW393578B (en) A test device and method for the determination of protein in a biological sample
EP1410001A1 (en) Multilayer analytical element and method for determination of analytes in fluids containing interfering substances
CN112304930B (en) Disulfide bond detection method and sputum detection kit containing disulfide bonds
CN108226147A (en) A kind of microdose urine protein detection reagent item and preparation method thereof
WO1990001699A1 (en) Method and means for allergy diagnosis
Immunoassay HUMAN FERRITIN ENZYME IMMUNOASSAY TEST KIT
JPH01259260A (en) Implement for detecting ascorbic acid

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MK4A Expiration of patent term of an invention patent